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Abstract
Macrophages are versatile and highly adaptive cells that are involved in a wide range of
physiological processes including host defense, homeostasis or regeneration, as well as
pathogenesis. They react to their microenvironment, assuming various roles based on chemical
and/or physical cues, and can reversibly shift between these so-called activation states.
Concurrently, the technique of immunohistochemistry is used to gain spatial information on
activated macrophages on tissue sections. The aim of this work was to find mass spectral
biomarkers that allow the differentiation of activation states, and establish conditions that can be
used in imaging mass spectrometry (IMS) experiments to investigate the spatial distribution of
differently-activated macrophages within tissue sections. The immortalized macrophage line
NR8383 (alveolar, rat) was used, and in vitro activated with the endotoxin lipopolysaccharide
(LPS), or with the cytokine interleukin-4 (IL-4). In IMS, tissue sections are commonly prepared
to be compatible with matrix assisted laser desorption/ionization (MALDI) mass spectrometry
(MS) experiments. The tested combinations of MALDI preparation techniques and instrument
parameters however remained unsuccessful at distinguishing activation states. Through lowering
the complexity of the sample with a 30 minute high-performance liquid chromatography (HPLC)
separation, a reproducible biomarker for LPS-activation could be found in electrospray
ionization (ESI) MS experiments. The isolated biomarker was subjected to a tryptic digestion,
and the resulting tryptic fragments analyzed by MALDI MS. A MASCOT database search
suggested the macrophage-capping protein (CAPG) as source of the peptide, which could be
validated through peptide sequencing through post-source decay experiments conducted on the
tryptic fragments.
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Chapter 1:Background and Significance
1.1. The Macrophage
1.1.1. A cell type with many functions
In mammals, the macrophage is a cell type that is widely distributed throughout the
organism, and can be found in every organ, and in most tissues.1,2 The precursor cells,
monocytes, are released into the circulatory system by the bone marrow, and differentiate into
macrophages upon migration into tissue.3 The term “macrophage” (greek, from makros "large"
and phagein "eat") was originally coined by Elie Metchnikoff based on his observation that
many microorganisms could be engulfed and digested by large mononuclear phagocytic cells.4
Though commonly regarded as only part of the innate immune system, it was later discovered
that macrophages are highly adaptive, versatile cells involved in a wide variety of biological
processes.2 These include host defense, immune regulation, as well as the orchestration of wound
healing and other homeostatic tasks.1,5 In response to the local microenvironment, macrophages
assume protective functions as in antimicrobial defense, in homeostatic or restorative roles as in
the wound healing process, and also in pathogenic functions, e.g. in tumorigenesis,
autoimmunity, or allergy and asthma.3

1.1.2. Macrophage activation
The distributed tissue-resident macrophages are remarkable in that they display a high degree
of plasticity, i.e. they can change their physiology based on chemical and physical cues from
their microenvironment.1,6 This process is called activation, and is defined as the perturbation of
macrophages by exogenous agents other than via the basal tissue microenvironment exposure.
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These cues include the broad category of signaling proteins called cytokines, as well as other
modulators like the presence of cell debris and the phagocytosis of proximate cells.7
The most prominent1 example of a microbial structure to trigger a physiologic response in
macrophages is lipopolysaccharide (LPS), a cell-wall component of Gram-negative bacteria. It
has been known since the late 1800’s8 to induce a strong reaction in affected organism.4 The
presence of LPS is detected by a transmembrane receptor, the Toll-like receptor 4 (TLR-4), on
the macrophage surface. The detection triggers an intracellular cascade leading to the formation
and release of antimicrobial peptides, the secretion of signaling molecules (particularly the
cytokine tumor-necrosis factor (TNF)), as well as to increased phagocytic activity and the
efficient production of effector molecules (reactive oxygen and nitrogen intermediates). This
particular stimulation of macrophages is referred to as classical activation.4,9
In 1992, Stein et al. presented their work on an alternative activation state of macrophages
induced through the treatment with the cytokine interleukin-4 (IL-4). They observed that, in
contrast to classical activated macrophages, the secretion of proinflammatory cytokines was
reduced and the capacity for endocytic clearance of mannosylated ligands was strongly
enhanced.10 This activation through IL-4 was later associated with a wound healing macrophage
phenotype.11-13
To parallel the nomenclature of T helper cell polarization, the classical and alternative
macrophage activation state are widely referred to as M1 and M2 respectively,14 whereas the
category of M2 grew over time with the discovery of more, distinct activation states to be
divided further into subcategories9 (activation states are sometimes also referred to as
polarization states).7
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Following a recent attempt in the field of macrophage activation to reorganize and clarify
experimental conditions and results,7 this thesis will follow the suggested guidelines to label LPS
treated macrophages as M(LPS) as well as the macrophages treated with IL-4 as M(IL-4).

1.1.3. Plasticity and its continuous nature
Not only do distinct states of macrophages exist, it could also be shown that the functional
phenotype of activated macrophages can be reversibly shifted with the help of different
stimuli.15-19 Expanding on the observation of this plasticity, Mosser et al. suggested that
macrophages can exist along a continuum in between three fundamental functions: host defense,
wound healing, and immune regulation. Illustrating this with a color wheel of macrophage
polarization, they argue that the function of activated macrophages exist as shades in between
these primary tasks.13 Consequently, the presence and quantity of biomarkers associated with
macrophage phenotypes has to be determined to gain insight into the current, predominant
function of the investigated macrophage population.

1.1.4. Common techniques to investigate macrophage activation
Macrophages have the ability to synthesize proteins to maintain cellular functions and to
perform tasks associated with their activation state. Proteins, also known as polypeptides, consist
in the simplest form of a chain of amino acids, and are produced in two major steps. During the
first step, the transcription, the genes on the macrophage’s DNA are transcribed into
corresponding RNA, which can be processed further to messenger RNA (mRNA). The encoded
information in the mRNA is then used in the second step, the translation, as a template for the
assembly of the polypeptide.20 These sequential steps are inherently tied to the synthesis of
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proteins, and so the activation state of macrophages can be explored by targeting the RNA21-24
and/or the polypeptide25-29 level of this process.
Both approaches, targeting the products of transcription or those of translation, are referred to
as the field of transcriptomics and proteomics, respectively, and have also been used to
investigate macrophages.30,31 The ‘omics’ in both terms imply that the aim is to capture virtually
all molecules of the respective category of an investigated organism under specified conditions,
and the evaluation of these data sets can grant insights into the inner workings of biological
processes.32

1.1.4.1. Transcriptomics
The expression of RNA, the transcriptome, is typically monitored and quantified using the
high-throughput technique of DNA microarrays.33 In this procedure, the extracted and purified
RNA sample is fluorescently labeled during reverse transcription, and then incubated on a chip
containing thousands of counter strands of DNA representing genes from the investigated
organism. During this incubation, complementary nucleic acid strands hybridize, and, after a
washing step to remove the weaker, non-specific adsorbed analytes, the identity and the quantity
of the analyzed RNA can be determined by the location and intensity of the fluorescent signal.34
Some of the limitations of this technique include that the preparation of the counter strand DNA,
the so-called probes that are applied to the chip during the manufacturing of the microarray, are
very labor intensive in the preparation, and the sequence information for them should, at best, be
derived from a complete genomic database of the investigated organism.34
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1.1.4.2. Proteomics
The polypeptides synthesized during the second step, the translation, are typically analyzed
by high-performance liquid chromatography (HPLC or short LC) mass spectrometry (MS), in
which a complex mixture of polypeptides is separated through the LC, and the eluting sample
subjected to mass spectrometry. By choosing from a wide variety of separation columns and
elution conditions, the LC can separate polypeptides according to inherent characteristics like
mass, hydrophobicity, or biospecificity. The eluting analyte can either be directly subjected to
mass spectrometric analysis through interfacing the LC with a MS through an electrospray
ionization (ESI) interface, or the eluting fractions can be collected, and after further processing
subjected to MS via matrix-assisted laser desorption ionization (MALDI).35 To render a large
mass range accessible to the mass spectrometric analysis, the analyte mixture is commonly
proteolytic digested to form peptide fragments,36 which are in a mass-to-charge range (<20 kDa)
amenable to routine mass spectrometric analysis.37 Mass spectrometry is predominantly regarded
as semi-quantitative in nature, since the ionization efficiency of the analyte is governed by
inherent characteristics of the analyzed compound, and this efficiency is additionally confounded
by suppressive/enhancing matrix effects. Hence, a widespread accepted method to obtain
quantitative information is the use of isotope-labeled reference peptides as internal standard.35,37
LC-MS based analysis employing the sample digestion step, however, suffer from inadequate
identification of polypeptides arising from alternative splicing. These isoforms of polypeptides
share a high percentage of amino acid sequence, and thus proteolytic fragments lose specificity
in the identification process.38,39
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1.1.4.3. Immunoassay-based method
Another technique to investigate the activation state of macrophages is based on the highly
specific antigen-antibody reaction. Cytokines that are released upon macrophage stimulation are
routinely detected, and quantified through enzyme-linked immunosorbent assays (ELISA).40 The
ELISA is a wet-lab based technique that uses the catalytic activity of an enzyme to convert a
substrate into a product which can be spectrophotometric quantified.41 This enzymatic signal
amplification allows for low detection limits, but the use of antibodies to capture specific
analytes limits this technique to the detection/quantification of specified target molecules, so that
no exploratory experiments with unknown biomarkers can be conducted with this technique.1

1.1.5. Modulation of macrophage response
Uncovering the many functions of macrophages in the body also revealed connections
between diseases and macrophage subsets.3,42,43 Unrestrained macrophage activity can be linked
to chronic inflammation,44 fibrosis,45,46 metabolic disease47 or the proliferation of cancerous
tissue.48,49 A further, not disease-related field in which alteration of macrophage function is
desirable, is the realm of medical implants and tissue regeneration after surgery. Here, the
promotion of tissue repair as opposed to triggering foreign body reaction is the desired
outcome.50,51
Targeting the activation state of macrophages with effector molecules is a promising
approach in resolving complications caused by dysregulated13 macrophage populations18 or to
ameliorate the impact of surgery and medical implants.51
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1.2. Investigating the spatial distribution of activated macrophages
As described above, there are instances in which the modulation of the macrophage response
is desired (e.g. to counter chronic inflammation, or to protect implants from encapsulation). As
pointed out by Stein et al,17 the biological microenvironment of macrophage populations
decisively influence the observed functional phenotypes, so it is desirable to conduct in vivo
experiments where the modulation agent is administered locally into the investigated tissue.
Consequently, unaltered tissue portions of the model organism can be investigated in a side-byside approach, and hence would serve as an internal standard that adjusts for biological
variability observed in between subjects. Additionally, the spatial distribution (e.g. proximity to
damaged tissue, or distance to the source of the modulator) of macrophage populations can be
analyzed and interpreted within the biological context.
To this end, the discussed transcriptomics and proteomic experiments, although yielding
abundant information on macrophage activation states, are impracticable with respect to the
amount of individual experiments that would have to be performed on small sections of a tissue
section. To answer general questions regarding spatial distribution of specific target molecules
on tissue samples, the well-established analytical tool of immunohistochemistry is commonly
applied.52

1.2.1. Immunohistochemistry –Common approach to investigate spatial distribution of markers
Immunohistochemistry is an analytical tool that uses the high specificity of the antibodyantigen reaction to locate and highlight (through conjugated fluorophores or via radio labeling)
the location of target molecules on tissue sections. Several steps are necessary to prepare a
sample for analysis: after explantation, the tissue sample is typically fixed through the use of
formalin cross-linking of the present biomolecules, followed by embedding in paraffin to
7

conserve the structural integrity. After sectioning the tissue into 5-15 µm thick slices and
transferring these to glass slides, the tissue sections are typically pre-treated to expose the analyte
for the following labeling step. The pre-treatment step aims to reduce the initially induced crosslinking, and thus make the sample more porous so that the labeling antibody can more easily
diffuse into the tissue and bind to the detection region, the epitope, on the antigen. This reduction
can be achieved through protease digestion, which can cleave proteins that are incorporated into
the cross-linked network, or through a technique called antigen retrieval, in which the epitopes
are rendered more accessible by heat-induced protein unfolding.
After the preparation of the tissue section, the actual step of immunochemically targeting the
analyte is performed. This is a two-step procedure, in which the tissue is first incubated with a
primary antibody expressed in a certain host (e.g. mouse, rabbit, goat, etc.) to selectively bind to
the molecule of interest, followed by the incubation with a secondary antibody targeting
antibodies derived from certain species (i.e. targeting mouse, rabbit, goat antibodies).
Additionally, the second antibody is conjugated to a reporter system like a fluorophore or an
enzyme that can convert its substrate into fluorescent product. The fluorescence of either reporter
system can then be used to obtain the spatial distribution of the targeted molecule with the help
of fluorescence microscopy.52
This method is widely accepted as tool in research and diagnostics, which is also reflected by
an increasing number of available primary antibodies from various host animals, and it has also
been used to investigate the distribution of activated macrophages.53 However, as Nuovo
details,52 there are various challenges and pitfalls that affect the quality of the obtained data.
Among these, it is emphasized that an optimized protocol for detecting a specific analyte in one
tissue section may not give rise to any signal at all when investigating a different type of tissue
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despite the presence of analyte. There is no a priori way to tell which tissue pre-treatment
method will improve the observed signal, or, in the worst case, could even result in complete loss
of it. During the lengthy multistep sample preparation, numerous steps are critical for the
observed overall result, so that the obtained results are best interpreted in comparison to samples
prepared side-by-side. Additionally, the commercial availability and specificity of primary
antibodies may not be given for the molecule of interest. To exacerbate this situation, the
inherent requirement of the employed two-antibody-system severely limits the amount of
different analyte that can be detected simultaneously on one tissue section (i.e. the selection of
species from which the primary antibodies are derived translates into what species-specific
secondary antibodies can be used without confounding the observed results). A similar problem
also arises from the requirement that the emitted fluorescence of the used reporter system cannot
spectrally overlap. The availability of suitable absorption/emission wavelengths of laserfluorophore-systems that can be used adds a similar constraint like the two-antibody-system to
the number of simultaneously detectable analytes.
To this end, an emerging technology extending the technique of mass spectrometry to
analyze spatial analyte distribution could overcome certain limitations of immunohistochemistry.

1.3. Mass spectrometry
1.3.1. Theory
Mass spectrometry is a technique to determine the molecular mass of molecules and atoms
by measuring the mass-to-charge (m/z) ratio of the respective ionized species. It can either
directly provide the elemental composition of the analyzed material in the case that the
determination of m/z is accurate enough so that only one combination of atomic masses (more
exactly, of the isotopes) can lead to the observed m/z, or provide this information indirectly by
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analyzing fragments of the (intentionally) fragmented ion of interest. Additionally, analyzing
those fragments can provide structural information on the investigated substance. Conceptually,
a mass spectrometer consists of an ion source, a mass-to-charge analyzer, and an ion detector.

1.3.2. Ion sources – Matrix Assisted Laser Desorption/Ionization and Electrospray Ionization
The task of the ion source is to generate charged analyte molecules. Additionally, these ions
have to be in the gas phase so that they can be separated according to their m/z with the help of
electrical and/or magnetic fields.37
The technique called matrix assisted laser desorption/ionization (MALDI)54 enabled the
production of mostly singly charged gas phase ions of large, nonvolatile, and potentially labile
molecules with little or no fragmentation of the parent ion from solid analyte. This effect, called
soft ionization, allowed the investigation of intact, non-volatile biopolymers of molecular
weights >1500 Da. Although some fundamental aspects of the mechanism are still subject to
research, a large body of experimental guidelines for successful MALDI experiments has
emerged over time.37,55 Typically, the analyte is mixed with a large excess of an organic matrix
compound, ranging from an empirical-derived molar analyte-to-matrix ratios of 1:100 to
1:10,000,000, and is most commonly co-deposited on a metal target from solution. For most
experiments, the dried co-crystal is then inserted into a medium to high vacuum (10-7 to >10-9
mbar) mass spectrometer, and the sample is irradiated with short pulses of laser light to generate
a plume containing ionized species that is then subjected to the mass spectrometric analysis.
Typically, nitrogen lasers (wavelength of 357 nm) or Nd:YAG lasers (wavelength of 355 nm
when the 3rd harmonic is used) are used with ultra-violet light absorbing matrices, and CO2 lasers
are used with matrices that absorb in the infrared range (bands of wavelengths around 9.4 µm
and 10.6 µm). Although models attempting to predict ionization efficiency of certain analyte
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classes, e.g. based on properties like gas-phase basicity, have been proposed, no model can
capture the entirety of the this complex process.56
The second major soft ionization technique is called electrospray ionization (ESI). In contrast
to MALDI, it produces stable gas phase ions from dissolved analyte. The ions are generated by
spraying a solution of analyte into an electric field. Only polar solvents are compatible, since
non-polar solvents lack the required conductivity necessary to produce charges through
electrochemistry. The initially generated charged, fine droplets disintegrate to smaller droplets
through increasing repulsive columbic forces as the solvent evaporates. After complete
desolvation of the non-volatile analyte, the resulting ion is typically multiply charged, which, in
contrast to singly charged ions from MALDI, allow for the observed mass-to-charge ratio to fall
into the range (< 20kDa) of most commonly used mass spectrometers, and thus allowing the
analysis of larger molecules than MALDI.37

1.3.3. Mass-to-charge analyzer – Time-of-flight and quadrupole ion trap mass spectrometer
The ions produced in the ion source are then separated spatially and/or temporally in the
mass-to-charge analyzer before they are detected. To illustrate this, both employed mass
spectrometer will be briefly discussed.
In a time-of-flight (ToF) instrument, the generated ions are extracted from the source into a
field free drift tube by the application of a pulsed acceleration potential on the order of 25-35
keV.
Equation 1.1 shows how this potential, V, is related to the resulting velocity, v, through the
number of charges, z, the elementary charge, e, and the ion mass, m:
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Equation 1.1: Kinetic energy of ions after acceleration
Re-arranging
Equation 1.1 as in Equation 1.2 demonstrates the inverse quadratic relationship between the
ion velocity and the m/z.
1

 2 z eV  2
v

 m 

Equation 1.2: Re-arranged equation 1 to show inverse quadratic dependence of v to m/z
To obtain the time-of-flight (tof), i.e. the time it takes the ions packages to travel from the
source to the detector, the instrument-specific geometric factor L is used according to the
definition of velocity as in Equation 1.3:

tof 

 m 
L

 L
v
 2 z eV 

1
2

Equation 1.3: Relation of time-of-flight (tof) to the mass-to-charge (m/z) of the timed ions
Ideally, all ions experience the same acceleration potential, and separate during their travel
through the field free drift tube according to their m/z, and are detected after their respective
time-of-flight (tof).37
This basic concept of time-of-flight measurements, generally referred to as linear ToF mode,
can be enhanced to address a spread in tof of ions of the same m/z caused by spatial and velocity
distributions of the initial ion packet. The underlying distribution in kinetic energies can be
compensated by reflecting the traveling ion packets with the help of an ion mirror onto a
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secondary ion detector. In this so-called reflectron ToF mass spectrometer, ions of identical m/z
but higher kinetic energy penetrate deeper into the ion mirror before being reflected, and hence
travel a slightly longer distance. The instrument is constructed in way that the secondary detector
is placed at the electronic focus plane of the mirror to benefit from the reduction in spatial
distribution of the traveling ion packets.37
Typically, a reflectron ToF mass spectrometer can be run in linear mode, in which the
reflectron is deactivated and the ions are detected with a primary detector located behind the ion
mirror, or in the reflectron mode, which allows for a lower spread in tof, and hence a better
resolution of arriving ion packets.
Additional to the focusing effect of the reflectron, it can also be used to observe fragment
ions from post-source decay (PSD). PSD refers to the behavior of ions to dissociate after the
acceleration of the ion packages, during the travel in the field free drift tube, but before reaching
the reflectron.57 The ions travel at a certain velocity based on their initial mass, but will separate
according to their new, reduced m/z when a second acceleration potential is applied. The socalled LIFT mode of the Ultraflex III ToF/ToF (Bruker Daltonics) is based on this principle, and
thus allows analyzing desorbed ions further by exploring the fragments produced through PSD.58
Another mass-to-charge analyzer is the 3D quadrupole ion trap (QIT). Here, the ions
generated in the source are stored in a quadrupole electric field generated by applying a radio
frequency (RF) potential to a ring electrode. The trapped ions are collisionally cooled through
inert buffer gas like nitrogen to reduce the amplitude of their random displacement from the m/z
specific orbit that they assume. The ions oscillate on concentric three-dimensional orbits
according to their m/z and the applied RF potential. Through ramping the amplitude of this
potential, ions of increasing m/z are sequentially ejected from the trap and are registered through
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their impact on a detector. The m/z can be determined from the necessary RF amplitude for the
ejection, and achievable separation of ions of different m/z is, among others factors, a
combination of the scan speed of this amplitude and the detection speed of the detector. A
constraint for the amount of ions that can be detected simultaneous is imposed by the so-called
space-charge effect. This effect, in which the oscillating ion packets perturb each other’s orbit,
limits the charge density that can be achieved in a QIT. This problem is addressed by measuring
the ion flux in an initial pre-scan, followed by adjustment of the ionization time to produce a
target amount of ions (depending on manufacture, this is called automatic gain control (AGC) or
ion-current control (ICC)).

1.4. Imaging Mass Spectrometry – The transition from 1 to 2 dimensions
Imaging mass spectrometry (IMS) is the application of mass spectrometric methods to
spatially distributed samples like thin biological tissue sections. This is essentially achieved by
probing a surface in an x,y-fashion, and was driven by technological advancement of the mass
spectrometric field with respect to acquisition speed of traditional mass spectra, as well as
innovations aiming at conservation of information of spatial distribution of analytes.59 The major
advantage of this approach lies in the ability of mass spectrometry to measure hundreds of
different ions simultaneously without the need for molecular tags as in labeling for
immunohistochemistry, and it is therefore also suited for exploring a sample without a priori
knowledge of composition.60 Particularly, the combination of MALDI with IMS offers the
advantage of providing information of spatial distribution of small molecules like drug
metabolites up to large, intact proteins of up to 100 kDa.61 According to Goodwin is “[t]he upper
limit for reasonably sensitive detection […] currently around 25-30 kDa”, since MALDI tends to
generate only singly charged ions, but on-sample enzymatic digestion can provide indirect
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information on larger proteins.62 Techniques like desorption electrospray ionization (DESI)
additionally aim at combining the advantage of multiply charged ions as commonly observed in
electrospray ionization with the ability to scan a surface under atmospheric conditions.63

1.5. Approach
The following chapter describes the experiments conducted with MALDI MS in preparation of
MALDI IMS for macrophage activation studies. The scope of this work was to establish a robust
method to distinguish the activation state of macrophages on explanted tissue sections. To this
end, an in vitro activated immortalized macrophage culture was used as a readily accessible
model to test combinations of lysis and sample preparation protocols to find suitable biomarkers
that allow the unambiguous identification of the induced activation state. For this, the wellestablished approach of mass spectral fingerprinting37 was employed, which has been
demonstrated to allow reproducible identification of bacteria down to the strain level.64 Also
mammalian cell lines, which exhibit a less stable MS fingerprint,65 could be rapidly
characterized and cross-contamination of cultured cell lines could be readily distinguished with
this technique,66 suggesting mass spectral fingerprinting to be a suitable approach. It should also
be noted that Quedraogo et al. published data on MALDI-TOF MS of activated macrophages
(human), claiming that “The fingerprints induced by the M1 agonists, IFN-γ, TNF, LPS and LPS
+ IFN-γ, and the M2 agonists, IL-4, TGF-β1 and IL-10, were specific and readily identifiable.”.67
However, central claims, like the identification of peaks at m/z of 6827 or 6826 as related to the
activation state M1, while peaks at m/z 6835 or 6833 are supposed to indicate activation state
M2, are in contrast to the author’s criteria for similarity across spectra of a 2000 ppm m/z
window, which would encompass all the claimed different m/z values. Further, none of the ions
representing these biomarkers were identified, so supporting the claim of distinguishing
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activation states cannot be placed into the biological context, which would give the claim more
weight. Among other inconsistencies, the author further omits crucial information on the sample
preparation process like the solvent that was used to prepare the MALDI matrix, as well as the
matrix concentration, rendering this publication an unreliable source for own experiments.
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Chapter 2:MALDI of in vitro activated macrophages – Preparation for MALDI IMS
As discussed in Chapter 1, mass spectrometry-based proteomic experiments suggest an
abundant array of biomarkers for macrophage activation states. However, these biomarkers were
identified in elaborate experiments involving several steps that reduced the complexity of the
investigated sample. The advantage of the MALDI approach, on the other hand, is its simplicity
and reproducibility. As described above, though, the ionization efficiency of analytes cannot be
predicted, so the majority of tested experimental conditions are based on loose guidelines derived
from previous experiments reported in the literature.

2.1. Experimental section
2.1.1. Chemicals and equipment
2,5–dihydroxybenzoic acid (2,5-DHB, 99% purity), 1,5- diaminonaphthalene (1,5-DAN, 97%
purity), 2-hydroxy-5-methoxy benzoic acid (99% purity), 2,5-dihydroxyacetophenone (2,5-DHAB,
98+% purity), diammonium hydrogen citrate (99+% purity), and trifluoroacetic acid (TFA, 99%
purity) were purchased from Alfa Aesar (Ward Hill, MA, USA). 3,5-dimethoxy-4-hydroxy
cinnaminic acid (sinapinic acid, SA, 98% purity), and α-cyano-4-hydroxycinnamic acid(CHCA, 97%
purity) were purchased from Acros Organics (Geel, Belgium). The solvents acetonitrile (HPLC
grade), and methanol (HPLC grade) were from EMD Millipore (Billerica, MA, USA), ethanol (USP
grade) from Koptec (VWR, Radnor, PA, USA), and de-ionized water (HPLC grade) were purchased
from Thermo Fisher Scientific (Waltham, MA, USA). The MALDI targets with non hydrophobic
surface were purchased from Hudson Surface Technology (Fort Lee, NJ, USA). ZipTip® (OMIX 96

C18, 100 µL) where obtained from Agilent Technologies (Santa Clara, CA, USA).
For the cell culture, the immortalized macrophage cell line NR8383 (rat, alveolar, CRL2192), and the F-12 K medium (Kaighn's modification of Ham's F-12 medium) were purchased
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from ATCC (Manassas, VA, USA). Fetal bovine serum (regular, heat inactivated) was purchased
from Corning/Mediatech (Corning, NY, USA), and antibiotic antimycotic solution (100x,
stabilized) was obtained from Sigma Aldrich (St. Louis, MO, USA). The cytokine interleukin-4
(IL-4, recombinant, rat, 25 µg) was obtained from R & D systems, Inc. (Minneapolis, MN,
USA), and lipopolysaccharide (LPS, salmonella typhimurium) was purchased from EMD
Millipore (Billerica, MA, USA).

2.1.2. Matrix selection, deposition, and general method development
Matrices were chosen based on suggested37 application to investigate small (<10 kDa)
proteins/peptides (α-cyano-hydroxy cinnamic acid, CHCA), and heavier (>10 kDa) proteins (3,5dimethoxy-4-hydroxy cinnamic acid, “sinapinic acid”, SA), as well as the all-round matrix 2,5dihydroxy benzoic acid. In an attempt to investigate potential larger molecules than the
postulated sensitivity cut off of 25-30 kDa,62 two additionally matrices were investigated: 1,5diaminonaphthalene (1,5-DAN) is known to promote in-source decay (ISD),68 which allows
identification of larger proteins through the detection specific fragments, and which was
demonstrated in MALDI IMS experiments on tissue sections (parent ions up to 70 kDa).69,70 The
matrix 2,5-dihydroxyacetophenone (2,5-DHAB) promotes the generation of multiply charged
ions from MALDI,71 so it was tested for its ability to reduce the m/z of larger ions by increasing
the charge.
For the deposition of matrix/analyte onto the stainless steel MALDI target, three standard
methods where investigated: The simple “dried droplet”,72 where the matrix and analyte are
mixed in solution before spotting, along with the related “fast evaporation” technique,73 where
the matrix is pre-spotted to form very fine crystals during solvent evaporation (seconds to a few
minutes) prior to the application of dissolved analyte, and the “sandwich” technique, a
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modification of the fast evaporation technique, wherein an additional layer of matrix solution is
applied on top of the dried matrix-analyte layers.
The method development was conducted in an iterative way, in which changes to the
preparation protocol were tested side-by-side with previously established protocols. The
resulting mass spectra were then compared and inspected for its information density (i.e. ion
signal density of differing m/z), reproducibility, and for potential biomarkers (in case sample
derived from differentially activated macrophages was investigated, see below). All tested
combinations were usually spotted in three technical replicates, and in at least three analyte-tomatrix-ratios. Since the sample here is generally a complex mixture without a known
concentration of its individual components, the mixing ratio of analyte-to-matrix was varied by
variation of proportion of mixed volumes of matrix and analyte solution. Further, new methods
were tested with readily available non-polarized (i.e. quiescent) NR8383 macrophages, and, if
MS spectra suggested that additional information (compared to the established procedure) could
be obtained, the method was repeated with the lysate of polarized macrophages. Table 2.2
displays a selection of preparation methods with the respectively, most commonly, used matrix
concentrations, employed solvent system, and application techniques.

2.1.3. Explored solvent systems for macrophage extraction
In an attempt to investigate the impact of extraction solvent on the observed mass spectra,
aliquots of approximately 1 x 106 quiescent macrophages each were extracted with 100 µL of
various solvent systems. The hypothesis was that molecules could be differentially extracted
based hydrophobicity, and hence the observed mass spectra would be altered to display differing
groups of analytes. All samples were prepared with 2,5-DHB (1M, 90% methanol, 0.1% TFA) in
the dried droplet preparation. The choice of investigated solutions was loosely based on solvents
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commonly employed in MALDI matrix preparations. Further, the impact of acidity of the solvent
system on the extraction was explored by comparison of extractions performed with 0.1 % (v/v)
TFA, and 2.1 % (v/v) TFA. Table 2.1 depicts the tested extraction solvents.
Table 2.1:Overview of solvent systems explored for macrophage extraction
Solvent
water
water
methanol (50% (v/v) in water)
methanol (90% (v/v) in water)
acetonitrile (60% (v/v) in water)
acetonitrile
acetone (90% (v/v) in water)

Additive
n-octyl β-glucopyranoside (OβG), 0.1% (w/w)
trifluoro acetic acid (TFA), 0.1% (v/v) and 2.1% (v/v)
TFA, 0.1% (v/v)
TFA, 0.1% (v/v)
TFA, 0.1% (v/v)
TFA, 0.1% (v/v)
TFA, 0.1% (v/v)
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Table 2.2: Selection of matrix molecules and preparation conditions investigated in the direct MALDI of macrophage lysate
Matrix

Concentration/solvent

Application technique

1 M in 90% methanol, 0.1% TFA
2,5-dihydroxy benzoic acid

dried droplet
1 M in 33% (acetonitrile/H2O, 0.1% (v/v) TFA in H2O)
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"super" 2,5-dihydroxy benzoic acid
(= 9:1 (w/w) ratio of
2,5-dihydroxy benzoic acid
to 2-hydroxy-5-methoxy benzoic acid)

50 mg per mL in 50% (acetonitrile/H2O, 0.1% (v/v) TFA in
H2O)

dried droplet

α-cyano-hydroxy cinnamic acid

saturated, in 30% (acetonitrile/H2O, 0.1% (v/v) TFA in H2O)

dried droplet

0.1 M in 90% methanol, 0.1% TFA

dried droplet

target pre-spotted with saturated solution (in ethanol);
sample mixed 1:1 with
30% (acetonitrile/H2O, 0.1% (v/v) TFA in H2O)

layer technique

1,5-diaminonaphthalene

saturated, in 50% (acetonitrile/H2O, 0.1% (v/v) TFA in H2O

dried droplet

2,5-dihydroxyacetophenone

0.133 mol/L in ethanol, mixed 3:1
with 0.08 mol/L diammonium hydrogen citrate
(acidified with 2% TFA solution (1:1) prior to deposition)

dried droplet

3,5-dimethoxy-4-hydroxy cinnamic acid
(“sinapinic acid”)

2.1.4. Sample preparation: Culturing, activation, and harvest of macrophages
The immortalized macrophage cell line NR8383 (rattus norvegicus; alveolar) was obtained
from the American Type and Culture Collection (ATCC), and the macrophages were cultured
according to the protocol described by Helmke et al.74 Briefly, the macrophages were incubated
at 37°C in a Ham’s F12K medium containing 15% fetal bovine serum and 1%
antibiotic/antimycotic solution. The medium is changed about twice a week, and cultures are
split occasionally when the culturing flask wall appeared to be covered with attached cells.
The process of changing the media consisted of retrieving the nutrient-depleted media from
the culture flask, and replenishing the flask with fresh complete media. The retrieved media
contains floating macrophages (approximately half of the present cell population),75 which are
concentrated into a cell pellet by centrifuging at 140-250 g for 10 min (supernatant is decanted).
These macrophages were either used for activation experiments as described in the following
paragraph, or directly processed for experiments on quiescent macrophages (washed once with
100 µL of HPLC grade water and further processed as described in the macrophage work-up
protocol section). Either way, the macrophage counts were generally estimated with the help of
an automated cell counter, Invitrogene CountessTM, based on the technique of staining with
trypan blue.76 For this, a sample of 20 µL of the re-suspended pellet was mixed with 20 µL of the
trypan blue dye, and the mixture was analyzed according to manufacturer’s instructions. In the
case of activation experiments, the cell pellets were re-suspended in 5 mL of complete media, the
macrophage count was established, and the sample were further diluted to yield approximately 5
x 105 macrophages/mL.
These sub-samples of the harvested NR8383 macrophages were treated once with the
endotoxin lipopolysaccharide (LPS) at a concentration of 200 ng per mL of cell suspension,
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while for the induction of the M(IL-4) state, sub-samples of similar cell count were treated with
the cytokine interleukin-4 (IL-4) at a concentration of 50 ng per mL of cell suspension.77 While
the M(LPS) state is reached within 24h (detected by the release of the cytokine tumor necrosis
factor alpha (TNFα)78), the cell culture had to be treated repetitively each day for 2 days to
detectably form M(IL-4) (confirmed by the production of the cytokine interleukin-10 (IL-10), the
absence of TNF, and low levels of IL-6, as detected in an ELISA assay).

2.1.5. Macrophage work-up protocol – Overview and evolution of lysing technique
Starting with a mass-spectrometry sample-preparation method for chicken macrophages,79
the protocol was modified in a systematic way. Major changes (e.g. changing the lysing method)
were evaluated based on reproducibility and information density of the obtained mass spectra,
and new methods were compared with preparation procedures previously established. To
minimize the impact of biological variability on this iterative process, previous and the new
procedure were performed side-by-side on subpopulation of the same batch of harvested
macrophages. Initially, the results on quiescent macrophages were evaluated, before polarized
macrophages were investigated. Table 2.3 gives a chronological (top to bottom) overview of the
explored sample preparation methods.
The initial lysing technique consisted of trituration of macrophage cell pellets in a small
amount (40-200 uL) of 0.01%-0.1% (w/v) n-octyl β-glucopyranoside solution (a non-ionic
detergent).79 Based on the observation that the macrophage pellets could be extracted multiple
times to obtain sample solution that would produce similar mass spectra, it was concluded that
the cell lysis was incomplete, so a more rigorous and reproducible automatic mechanical lysing
protocol involving a bullet blender®80 was investigated. Further, two freeze-thaw protocols,81,82
an ultra-sonication approach, and finally a lyophilization procedure were explored, and the
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obtained MALDI spectra were compared to determine the most effective, reproducible procedure
that maximized obtained signal intensity and amount of unique ions of differing m/z.
As basis to evaluate new lysing methods, the generally well-established and preparationinsensitive83 matrix 2,5-dihydroxy benzoic acid (c=1mol/L) in 90% methanol (0.1% (v/v)
trifluoroacetic acid) was mixed with macrophage lysate at various mixing ratios (usually 3
ratios, to reduce the chance that no ions where generated merely because of an analyte-matrixratio mismatch), and spotted in the dried droplet technique.
Additionally, while evaluating new lysing techniques, an already evaluated method was
carried out side-by-side on an aliquot of the analyzed sample solution in order to have a direct
reference, so that biological variation in the cultured macrophages, or instrument performance
would not interfere with the evaluation process. Further, the cell count of each sample solution
was taken into account with respect to solvent volumes, if possible, when the lysate solutions
were constituted.
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Table 2.3: Overview of macrophage lysing methods (in chronological order from top to bottom)
Method
Mechanical lysis
(manual)

Analyte
non-polarized NR8383
(pelleted at 2000rpm (=250xg)
for 10min)

Lysing technique
Triturated (ground with pestle)
in 200μL 0.01% (w/v) OβG

Lysate preparation
centrifuged at 13500rpm
(=12,225xg) for 10min
to sediment cell debris
centrifuged intially at
13500rpm (=12,225xg)
then at
10000rpm (=9056xg)
for 10min
to sediment cell debris

polarized NR8383
(pelleted at 2000rpm (=250xg)
for 10min)

Bullet blender®
(Next>>>Advance)
in 10 μL 0.01% or 0.1% (w/v)
OβG
with ZrO2 beads

Freeze-thaw

non-polarized NR8383
(pelleted at 2000rpm (=250xg)
for 10min)

Freeze-Thaw (frozen at -20°C,
stored for 3 days)
in 100μL H2O
defrosted in lukewarm water
(3min)

10000rpm (=9056xg) for 10min

Ultra-sonication

non-polarized NR8383
(pelleted at 1100rpm (=138xg)
for 10min)

Ultrasonic bath for 20min
(cells in 40μL 0.1% (w/v) OβG)

10000rpm (=9056xg) for 10min

non-polarized NR8383
(pelleted at 1100rpm (=138xg)
for 10min)

Snap-frozen (liquid N2)
in 40μL FT lysing buffer or
0.1% (w/v) OβG
3x freeze-thaw cycles
(defrosted on ice)

10000rpm (=9056xg) for 10min

Mechanical lysis
(automated)
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Freeze-thaw
(modified)

Re-suspension in solvent
(mostly H2O)
Lyophilization
optional trituration
sedimentation of cell debris by
centrifugation
n-octyl β-glucopyranoside (OβG), 2,5-Dihydroxy benzoic acid (2,5-DHB), Methanol (MeOH), trifluoro acetic acid (TFA)
polarized NR8383
(pelleted at 1100rpm (=138xg)
for 10min)

Snap-frozen (liquid N2)
(just the cell pellet)
lyophilized for ~20h
(pressure <50mbar)

2.1.6. Optional desalting of macrophage lysate
The performance of matrices are generally regarded as quite sensitive to nonvolatile salts,
which effectively prevent the ionization of analytes during the MALDI process.37 To probe for
detrimental concentration of salts (remainder from culture media, as well as originating from
cytoplasm released during cell lysis) were present and inhibited ion signals, macrophage lysate
was additionally desalted by the use of ZipTip® pipette tips and investigated with 2,5-dihydroxy
benzoic acid. Essentially, a ZipTip® is a pipette tip that has a bed of chromatography media
actin as the stationary phase incorporated in the tip, C18 in the evaluated case, to adsorb/partition
analyte during the loading step, retain it during washing steps, and should release it in the elution
step (due to appropriate solvent strength) (see Table 2.4). In this manner, it ideally concentrates
and purifies targeted analyte.
Table 2.4: Employed ZipTip® (OMIX, 96 C18, 100 μL) desalting protocol
Solvent/solution
100 µL 0.1% TFA in acetonitrile
100 µL 0.1% TFA in water
Sample solution
100 µL 0.1% TFA in water
20 µL 0.1% TFA in 60% acetonitrile

Up&Down pipetting
Purpose
(number of repetitions)
20
Pre-conditioning of ZipTip®
20
30
Loading of ZipTip®
Washing step;
40
replaced washing solution
after every 10 repetitions
Elution/concentration of
35
retained sample

To check the retaining capability of the stationary phase, and for possible mass
discrimination effects, the solution that was used to load the tip was analyzed by MALDI as well.

2.1.7. MALDI-TOF MS system and settings for analysis of mass spectra
The majority of the presented MALDI work on the activated macrophages was carried out on
a Bruker Reflex III time-of-flight (ToF) instrument (Bruker Daltonics) equipped with a Nitrogen
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laser (VSL-337 ND, LSI Laser Science, Inc), operating at 337 nm wavelength and laser shot
frequency of 10 Hz. The mass spectrometer was used in positive ion mode, and both available
configurations were investigated for their respective benefits: the linear mode, which permits a
lower limit of detection, and the reflectron mode, in which an electrical ion mirror is used to
compensate for a spread in the kinetic starting energies of the ions generated in the plume, and
therefore allows for a higher resolution of the ion packages arriving at the detector. The ions
were typically accelerated by the application of 26.5 kV (25 kV in reflectron mode) and focused
by a potential of 14 kV applied to a focus lens. For the reflectron mode, the ion packages were
deflected onto the detector by a potential of 26 kV applied to the ion mirror. Initially, methods
were optimized to record spectra in reflectron mode (900 – 8000 m/z), and for the linear mode in
the range of 2000 – 20000 m/z. The external calibration of the instrument was performed using a
solution of peptide calibration standard II (Bruker Daltonics Inc., Billerica, MA,USA) containing
Bradykinin fragment 1-7, angiotensin II, angiotensin I, , substance P, bombesin, Renin substrate,
ACTH clip 1-17, ACTH clip 19-39, and Somastostatin 28 and 1 mol/L 2,5-DHB matrix solution
{[M+H]+: 757.4, 1046.5, 1296.7, 1347.7, 1619.8, 1758.9, 2093.1, 2465.2, and 3147.5} for the
reflectron mode, or protein calibration standard I (Bruker Daltonics Inc., Billerica, MA,USA)
containing Insulin, Ubiquitin I, Cytochrom C, Myoglobin with 1 mol/L CHCA matrix
solution{[M+H]+: 5734.51, 8565.76, 12360.97, 16952.30 [M+2H]2+: 6180.99, 8476.65} for the
linear mode.
The mass spectra were analyzed with FlexAnalysis 3.3 software (Bruker Daltonics). For
spectra recorded in the linear mode, typically the baseline was subtracted (TopHat algorithm)
and a SavitzkyGolay filter (10 m/z width, 2 cycles) was applied to smooth the spectra to aid in
peak picking (centroid mode, 20 Da width at 80% height, signal-to-noise threshold of 100). For
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spectra obtained in reflectron mode, the baseline was subtracted (TopHat algorithm) and the
SavitzkyGolay filter (0.5 m/z width, 1 cycle) was applied to smooth the spectra to aid in
automatic peak picking (centroid mode, 1 Da width at 80% height, signal-to-noise threshold of
6). The intensity of all presented MALDI spectra is normalized in a way that the most intense
peak is considered 100%, and the remaining peaks are relative to it in their depicted size. This is
to emphasis the relevance of the exhibited fingerprint, and not the absolute signal intensity,
which would be generally given in instrument-specific arbitrary units. It should further be noted
that the shift of observed m/z in the mass spectra is mainly due to a combination of the difference
in sample morphology (i.e. the thickness of the prepared matrix co-crystals, the following
difference in distance of the generated ions to the acceleration electrode, and the resulting
differential amount of absorbed kinetic energy upon acceleration) and the lacking ability to
efficiently compensate for this in the linear ToF mode of the employed, dated instrument. A shift
of the observed m/z by +/- 10 Da across the MALDI spectra generated in the linear mode was
accepted as long as this trend was consistent within the spectrum.

2.2. Results and discussion
2.2.1. Impact of matrix selection on observed mass spectra
With the exception of 1,5-diaminonaphthalene (1,5-DAN), all investigated matrices (Table
2.2) yielded spectra of the macrophage lysate in the investigated range of 2000-20000 m/z (see
Figure 2.1). 2,5-dihydroxybenzoic acid (2,5-DHB) prepared in 90% methanol with 0.1% TFA
was under the investigated conditions the most reproducible matrix with respect to observed
unique ions, and relative ion intensities. 3,5-dimethoxy-4-hydroxy cinnamic acid (“sinapinic
acid” SA) resulted in equally information-dense spectra. In the case of SA, only the dried droplet
preparation was initially employed, which exhibited a relative high fluctuation in observed
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relative ion signal strength (see comparison of 2,5-DHB vs SA, Figure 2.2), which lead to the
preferential use of 2,5-DHB. At a later stage, though, the layer preparation of SA was tested, and
found to be of advantage based on the identical amount of observed ions (when compared to 2,5DHB), but increased homogeneity of the applied sample.73 Figure 2.3 depicts spectra recorded in
the reflectron mode (top), and the linear mode (bottom) of macrophage lysate spotted in the dried
droplet method with an equal volume of 2,5-DHB dissolved in 90% methanol/0.1% TFA. The
inset shows the most conserved fingerprint region of the sample in the range of 3900 – 6500 Da
m/z in an overlay of the reflectron and the linear mode. This display further demonstrates the
enhanced peak resolution of the reflectron mode compared to the linear mode, which was used to
investigate potential unresolved, unique ion signals. This fingerprint, especially the most intense
peak around 4960 Da, was observed with every tested matrix (with the exception of 1,5-DAN)
with differing relative intensities of the observed peaks. This prominent peak was found to be
thymosin beta-4, an actin-binding peptide, typically abundantly present and characteristic for
monocytes/macrophages, by Kannan et al. in chicken macrophage.79
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Figure 2.1: Overview of mass spectra produced from macrophage lysate spotted with matrices according to Table 2.2. From
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2001.7 Cell lysates in SA
4974.5
3979.1

Technical replicate
#1
6178.4

5178.6

2669.9

7025.5

4402.7
4239.8 4986.9

3478.9

3977.0
7002.3

31

3980.3
4405.9
4993.4

2668.
4
3000

5000

7055.6

4970.0 Technical replicate
#2

2016.6

6000

7018.8

6184.8

3992.4
4579.4
3458.7

7018.5

4995.4 Technical replicate
#3

Technical replicate
#3
6182.1

5633.7
4000

6219.4
4604.4

6174.1

2667.2

2000

4014.6

2028.0
Technical replicate
#2

2000.6

2001.7

4995.8 Technical replicate
#1

Cell lysates in DHB

2024.9

7000m/z

2500

6213.5

4009.4
4600.1
3476.8
3500

4500

7047.9
5500

6500 m/z

Figure 2.2: Comparison of reproducibility of cell lysate spotted with sinapinic acid (SA, dried droplet preparation, left), and
with 2,5-dihydroxy benzoic acid (2,5-DHB, right). Both sides represent technical replicates prepared with the same sample.

4963.55

Reflectron mode

Overlay of spectra from both modes
4963.55

1329.57
2016.04

3989.87

6178.68

2482.54
Linear mode

4958.7
3989.87

4415.05

32

4252.73

5343.5

4000

6178.68

4739.54 5099.36

4500

5000

5500

6000

m/z

5365.1
3983.5
4569.8
2675.1 3453.4

2010.3

6174.4
5765.7

8446.3
9934.1
7004.9 7879.2
9068.2

11538.7

13043.6

m/z
2000
4000
6000
8000
10000
12000
Figure 2.3: Mass spectra of macrophage lysate (NR8383 cells) spotted with 2,5-dihydroxy benzoic acid (1M in 90% methanol,
0.1% trifluoroacetic acid). Spectra recorded in reflectron mode and displayed in the m/z mass range of 900 – 7000 Da (top),
and spectra recorded in the linear mode with the m/z range of 1900 – 135000 Da displayed (bottom). The inset depicts an
overlay of both modes to demonstrate difference in obtained peak resolution, and to show the preserved fingerprint region,
3900 – 7000 Da, of the NR8383 macrophages.

2.2.2. 2,5-DHB: Macrophage cell dilution experiment and desalting effect
Investigating the performance of the matrix 2,5-DHB further, the required minimum amount
of macrophage cells to obtain similar fingerprints as depicted in Figure 2.3 was explored, as well
as the impact of nonvolatile salt.
In a dilution experiment, in which macrophage lysate was diluted and prepared at decreasing
concentrations with 2,5-DHB (1M, dissolved in 90% methanol, 0.1% TFA, dried droplet) it
could be observed that, by the calculated dilution factor, lysate corresponding to approximately
900 macrophages would suffice to produce the observed fingerprint (Figure 2.4). However, this
number can be seen as upper limit, since this experiment was carried out with the initial lysing
technique that could be optimized in later experiments (see below).
The application of the ZipTip® protocol did not improve the observed signal intensity or
produce additional peaks. Instead, strong mass discrimination were observed (Figure 2.5). While
the sample that was eluted as the purified product was enriched in signals representing ions up to
≈1350 m/z, and depleted in signals representing higher m/z ions, the solution that was used in the
loading step exhibit the opposite behavior. This indicates an analyte retention problem, which
could possibly be alleviated through adjustments in the protocol (e.g. less concentrated loading
solution, different solvent systems for washing/eluting, general variation in step order/repetition).
However, it does not seem necessary to desalt the sample, since 2,5-DHB seems tolerant enough
for the trace levels of salt in the analyte solution, so the additional step of desalting was omitted
in the work-up protocol, as it would also be impracticable to apply to tissue sections.
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Figure 2.4: Amount of macrophage cells needed to produce typical mass spectral fingerprint. Lysate was produced by initial
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Figure 2.5: Result of ZipTip® extraction/desalting. Purified macrophage lysate (top), analyte remaining in the extracted lysate
(middle), and reference spectra of lysate without ZipTip® extraction.

2.2.3. Effect of extraction solvent and acidity
Surprisingly, all but acetonitrile/0.1% TFA, which did not produce any signal at all, of tested
solvent systems (Table 2.1) produced mass spectra (see Figure 2.6) exhibiting the dominant
fingerprint region in between 3900 – 6500 Da m/z, with only minor variation of unique, low
intense peaks in the remaining m/z range. This result could indicate that the ions representing this
fingerprint region are very efficiently ionized, and hence scavenge most of charges present in the
MALDI plume,84 almost independently of how well they are extracted based on their respective
hydrophobicity. In contrast, extracting the macrophages with 2.1 % (v/v) TFA drastically
changed the observed mass spectra (Figure 2.7) compared to Figure 2.3. Approximately two
times more unique ions could be observed within the range of 1500 – 6000 m/z, while, at the
same time, the observed relative signal intensity of the fingerprint region seemed to become less
reproducible. A close investigation of this phenomenon, however, revealed that the obtained
spectra are not reproducible, exhibiting differing unique ions almost each repeated experiment.
This may indicate that molecules of higher mass, especially proteins, could be randomly
hydrolyzed to produce fragments of very unsteady nature, which excludes the approach of
increasing the content of TFA to 2.1 % (v/v) in the preparation protocol.
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Figure 2.7: Mass spectra of macrophage cell pellets extracted with 2.1% TFA, and spotted in dried droplet with 2,5-DHB from
90% methanol/0.1% TFA. Each spectra represents and individual extraction. It is noticeable that about 2 times more unique
peaks (in contrast to Figure 2.3) are present, but the comparison of the independently extracted cell pellets exhibits the lack of
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2.2.4. Impact of lysing method on observed mass spectra
Figure 2.8 shows a comparison of spectra obtained from macrophages subjected to three
different lysing techniques involving the bullet blender, freeze thaw lysis, and the sonication
approach (see Table 2.3). All samples were prepared from approximately 2 x 105 quiescent
macrophages and were spotted in the dried droplet technique with an equal volume of 2,5-DHB
dissolved in 90% methanol, 0.1% TFA. It can be noted that the observed fingerprint is
independent of the employed lysing method. However, the sonication approach was found to
provide the most intense signal based on the observation that sample spots could be probed
longer, and at different spots, for more overall signal.
Ultimately, the lyophilization approach was accepted as standard. It provided comparatively
strong signal as the sonication approach, but would also inhibit sample degradation by removal
of solvent, provide a long shelf life (lyophilized samples would exhibit identical LC-MS spectra
even after storage for >2 months at -20°), and would be compatible with future tissue section
preparation.

2.2.5. Mass spectra of differing activation states in 2,5-DHB
Figure 2.9 depicts representative mass spectra of macrophage lysate of quiescent, LPSactivated, and IL-4 activated macrophages prepared with 2,5-DHB (1 M in 90% MeOH / 0.1%
TFA) in dried droplet technique. Lysates of eight independent activation experiments (for each
activation state, and control macrophages) were analyzed (three technical replicates of each
sample), but no reproducible mass spectral fingerprint was found that would allow identification
of activation state.
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Figure 2.8: Overview of three differing lysing techniques: bullet blender (top), freeze thaw (middle), and sonication (bottom).
The lysate produced with each technique was spotted with 2,5-DHB in 90% methanol/0.1% TFA, and the obtained spectra
exhibit an identical mass spectral fingerprint.
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Figure 2.9: Representative mass spectra of macrophage lysate of quiescent (top), LPS-activated (middle), and IL-4 activated
(bottom) cells prepared with 2,5-DHB (1 M in 90% MeOH / 0.1% TFA) in dried droplet technique. All mass spectral
fingerprint appear indistinguishable from each other.

2.3. Need for separation – transition to LC-MS
Although the mechanism of MALDI has been subject of extensive research for the past 30
years, the desorption/ablation and the ionization process are still poorly understood. No unifying
model for analyte ion formation could be established so far, but both currently proposed models
consider charge transfer between the gas phase ions/molecules in the plume following the laser
irradiation a central mechanism of charge distribution.55 This dynamic process, however, is
influenced by numerous parameters,56 so the essential aspect, the reproducibility of observed ion
signal from complex mixtures, in the mass spectral fingerprint approach (as described in 1.5. ) is
of pure experimental nature.
In the case of the macrophage lysate, the mass spectral fingerprint, especially in the range of
4000 – 6500 m/z (compare inset Figure 2.3), appears to be well conserved across differing
activation states (Figure 2.9), differing extraction solvents (Figure 2.6), and, to a certain degree,
across different employed matrices (Figure 2.1). This could indicate the dominant and relative
strong ionizability of the corresponding molecules, and the concomitant suppression of other ion
signals that could potentially differentiate the activation states. To test this hypothesis, the next
chapter presents experiments on the separation of the complex mixture with the help of highperformance liquid chromatography, and resulting mass spectra of the eluting sample of lower
complexity.
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Chapter 3:HPLC-MS of in vitro activated macrophages
The transition to a protocol involving the separation step of liquid chromatography, and the
subsequent mass spectrometric analysis of the dissolved analyte through an electrospray (ESI)
source made it necessary to reconsider the MALDI MSI approach. Fortunately, liquid extraction
based methods for the analysis of tissue sections have been proposed as alternatives,85-87 and
automated, semi-continuous techniques were demonstrated to be compatible with HPLC.88-90

3.1. Experimental section
3.1.1. Chemicals and equipment
In addition to the chemicals and equipment used in chapter 2: ultra-pure water was obtained
through filtering (Milli-Q purified, resistivity of 18 MΩ per cm, Millipore Corporation, Billerica,
MA, USA). Microsampling vials, 0.25 mL C/T PP, and the appropriate caps, 11mm orange snap
PTFE/Sil, for the LC-autosampler were obtained from Sun-Sri (Rockwood, TN, USA). The
desalting/concentration tip (NuTip® C18, 10 µL) where obtained from Glygen Corporation
(Columbia, MD, USA).
Additional used equipment includes the HPLC-MS system consisting of Hewlett Packard
1100 liquid chromatography (now Agilent Technologies, Santa Clara, CA, USA), with the
Discovery BIO wide pore C18 column (15 cm x 4.6 mm, 5 µm, obtained from Sigma-Aldrich
(St. Louis, MO, USA)) and the internal variable wavelength detector (G1314A) with a deuterium
lamp (G1314-60100), and a semi-micro flow cell (G1315-60011, 6 mm path length, 5 µL
volume) installed. The hyphenated mass spectrometer was an Esquire ion trap (Bruker Daltonics,
Billerica, MA, USA), and a fraction collector Model 2128 (Bio-Rad Laboratories, Hercules, CA,
USA) for the alternative setup. Additionally, the Ultraflextreme (Bruker Daltonics Billerica, MA,
USA) was used for MALDI ToF/ToF experiments. For sample preparation, the bench-top
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centrifuge VWR minifuge (VWR, Radnor, PA, USA), and the vacuum centrifuge CentriVap
DNA Centrifugal Concentrator (Labconco, Kansas City, MO, USA) were used.

3.1.2. Preparation of macrophage lysate extract
Macrophages were cultured and activated as described in chapter 2 (see 2.1.4. For reasons
described above (2.2.4. ), the harvested cell pellets of approximately 1-1.5 x 106 macrophages
each were lyophilized in a 1.5 mL Eppendorf tube to yield dry, powdered sample.
Each sample was extracted by re-suspending the powdered macrophages in 100 µL of
HPLC-grade water through up and down pipetting, followed by brief, vigorous vortexing to form
a slightly cloudy suspension. The solution was then centrifuged at 2000 g for 2 min to sediment
out the floating matter. After repeating this vortexing and centrifuging step once, 90 µL of the
supernatant was carefully removed with a pipette, and transferred to a 250 µL sample vial. All
prepared extracts were immediately analyzed by LC-MS to minimize any potential degradation.

3.1.3. LC-MS – Settings and evaluation of system
The liquid chromatograph was set up to run in binary gradient elution (Table 3.1) with 0.1 %
(v/v) formic acid in ultra-pure water as running solution A, and acetonitrile with 0.1 % (v/v)
formic acid as organic phase, B. Typically, 30 µL of sample was injected through the
autosampler, and the sample was separated at a flow rate of 0.5 mL per minute through the
reverse phase C18 wide pore column with a 30 min gradient elution. The eluting compounds
were either directed into the Esquire ion trap through the electrospray interface, or the eluting
solution was collected by the fraction collector (see below, 3.1.5. ).
In the case of direct infusion into the mass spectrometer, 4.2 kV were applied to the
electrospray needle, the solution was nebulized at 32 Psi (N2), and the solvent evaporation was
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enhanced by heated (300 °C) N2 sheath gas at a flow rate of 12 L per minute. The mass range
was set to 375 – 2000 Da m/z, the ion polarity was set to positive, the ion charge control (ICC) to
50000, and the ion scan rate to 2000 Da per second (lowest limit-of-detection, regular
resolution).
To evaluate signal stability of the LC-MS system, 30 µL aliquots (n = 3) of macrophage
lysate (extract from quiescent, and one from LPS-activated macrophages) were analyzed
consecutively (remaining lysate was stored in the fridge for the duration of each LC-MS run),
and the resulting spectra were analyzed as described below (3.1.6. ). Using actual lysate imposed
the constraint of limited sample volume (100 µL), but was deemed necessary to evaluate the
system stability under experimental conditions.

3.1.4. Development of HPLC elution protocol
In liquid chromatography, the analytes continuously partition between the stationary phase
(hydrophobic in the present case of the employed reversed-phase column), and the mobile phase
(relative hydrophilic due to the share of H2O in the running buffer).35 If other factors influencing
this partitioning like temperature, or column material are kept constant, the time it takes for the
molecules to traverse the column, i.e. the retention time, is a function of elution volume and
solvent composition. In the case of polypeptides, however, a “hydrophobic foot” can be the
result of sequences of hydrophobic amino acids, which then adsorbs to the hydrophobic column
material, resulting in complete retention. These molecules can only desorb and elute if a specific
number of organic modifiers, called ‘Z’ by Geng and Regnier,91 is reached. This desorption is
complete and instant once the very narrow concentration window of the organic modifier is
reached.92 Based on this, and on further considerations by Carr,92 the elution protocol was
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developed from a simple gradient elution (ramping from 2 % to 100 % acetonitrile within 30
min), to the stepwise protocol in Table 3.1.
Table 3.1: HPLC-gradient elution protocol
Time range
Increase in
Change rate
Comment
[min]
acetonitrile-% [% per min]
0 – 25
12 – 40
1.12
investigated range
25 – 30
40 – 95
11
cleaning step to avoid carry-over
30 – 35
95 (constant)
35 – 40
12 (constant)
equilibration of column for next injection
Used for separation of macrophage extract with Discovery BIO wide pore (C18) column
3.1.5. Preparation of collected fractions for MALDI
In the alternate set up, where the HPLC was attached to the fraction collector, samples of 1
min intervals were collected in 1.5 mL Eppendorf tubes. To confirm that the injected sample was
producing a similar LC-MS fingerprint in this situation, a regular LC-MS run on an aliquot of a
macrophage lysate was always performed right before fractions were collected, and, additionally,
the UV trace recorded at 254 nm by the internal detector of the HPLC was compared of both
successive runs to confirm correct timing of collection. Following the collection, fractions were
loaded without delay into the centrifugal concentrator to evaporate the solvent to dryness under
reduced pressure (< 20 mbar) and at elevated temperature (60 °C). Depending on the number of
simultaneously dried fractions, this took 2 to 6 hours.
The resulting residues were re-suspended by adding 7 μL of 15% acetonitrile/0.1% TFA (half
saturated with SA) to each dried fraction, followed by brief, vigorous vortexing to visibly cover
the inside walls of the respective Eppendorf tube. The liquid was collected at the bottom of the
container by centrifuging for 30 sec at 2000 g. 1.5 μL of the resulting analyte/matrix solution
was applied to a MALDI target pre-spotted with SA (Table 2.2, layer preparation) in technical
triplicates.
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3.1.6. Spectra processing, analysis and evaluation
LC-MS spectra were analyzed with DataAnalysis (version 4.0 SP 4 Build 281, Bruker
Daltonics). The default display mode is total ion chromatogram (TIC), in which the sum of the
signal intensities across the investigated m/z range of each recorded mass spectrum is plotted
against the elution time. However, increasing the percentage of acetonitrile leads to a general
enhancement of observed signal in ESI-MS with traditional columns (4.6 mm diameter),37 which
confounds the TIC by amplifying the chemical noise (see Figure 3.1), which was also
documented by the column manufacturer (organic modifier was 0.1 % TFA in methanol in the
described case).93 To address this, LC-MS spectra were visualized by base peak extracted
chromatograms (BPC), in which the most intense ion signal of each mass spectrum (integrated in
the range of +/- 0.5 Da) is plotted against the elution time. However, this display method was
always validated by manually evaluating the mass spectra (apex peak finder with S/N > 10 as
criteria) obtained during each individual chromatogram, and observed differences in signal
intensities were further explored by analyzing the corresponding mass spectrum for multiply
charged ions. To quantify ion signals, all charge states belonging to a molecule (e.g. the
annotated ion signals in Figure 3.4) were extracted (integrated +/- 0.5 Da of peak) and summed
up. This was displayed in extracted ion chromatogram (EIC) mode, and the resulting peaks in
EIC were integrated for quantification purpose. To compensate for observed performance drift of
ion signal intensities, as well as slight differences in extracted cell counts, the integrated ion
signals of each run were normalized by the sum of all ion signals observed within the same
experiment.94 Thus, the spectra are transformed from an absolute to a relative intensity scale,
allowing comparisons of molecular fingerprints obtained in the LC-MS experiments (an
alternative normalization based on the most intense peak at minute 10 resulted in the same
trend).
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To evaluate the standard deviation in observed signal introduced by the LC-MS system, 30
μL aliquots (three) of lysate from quiescent macrophages were consecutively analyzed (extract
was prepared immediately before the initial run, and kept at -20° in between injections). The EIC
of 10 multiply charged ions were integrated and the average, weighted, relative standard
deviation of these technical replicates was determined to evaluate reproducibility of the
performance of the employed LC-MS system.
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Figure 3.1: LC-MS chromatograms of experiments following the same gradient elution protocol (see Table 3.1) and displayed as total
ion chromatogram (TIC, top and middle), and as base peak extracted chromatogram (BPC, top and bottom). The top chromatogram is
an overlay of the TIC (rising line) and the corresponding BPC (flat line). This TIC (water injected as sample) demonstrates the raise
of the baseline with the increase of acetonitrile in the elution buffer. The chromatograms depicted in the middle (TIC) and at the
bottom (BPC) are differential display methods of the same raw data representing a typical LC-MS chromatogram obtained by
injecting quiescent macrophage lysate. The insets display a magnified version (minute 11 to 22) of the respective chromatograms
Note: scale difference

3.1.7. Tryptic digestion of collected fractions containing the potential biomarker and preparation
for MALDI experiment
After confirming (see Figure 3.1) that the potential biomarker would elute under the
employed elution protocol (Table 3.1) after ≈21.5 min, four fractions (minutes 21-22, 22-23, 2324, and 24-25) were collected. To increase the amount of sample for the digestion, a total of
three lyophilized, quiescent macrophage cell pellets (≈1.5 x 106 macrophages each) were
extracted with 100 µL each (as described above in 3.1.2. ), and 75 µL of each extract was
injected for LC-fraction collection. The combined (each elution interval combined separately),
dried fractions (as described above under 3.1.5. ), were each subjected to the in-solution
digestion protocol95 described in Table 3.2.
Table 3.2: Digestion protocol employed to digest collected, dried LC fractions of quiescent
macrophages
Description of step
Re-suspension of dried fraction in a total volume of 100 µL
of 50 mM NH4HCO3
 Addition of 5 µL 200 mM dithiothreitol solution
(prepared in 100 mM NH4HCO3)
 Boil for 10 min on a hot water bath
 Spin down (≈10 s at 2000 g)
 Incubation at room temperature for 1 h
 Addition of 4 µL 1 M iodocacetamide (prepared in
100 mM NH4HCO3)
 Brief vortexing, spin down (≈10 s at 2000 g)
 Incubation at room temperature for 1 h
 Addition of 20 µL 200 mM dithiothreitol solution
(prepared in 100 mM NH4HCO3)
 Brief vortexing, spin down (≈10 s at 2000 g)
 Incubation at room temperature for 1 h
 Addition of 5 µL of a 40 ng per µL trypsin solution
 Incubation at 37 °C for 18 h

Comment

Reduction of any present disulfide
bonds to form thiol (-S-H) groups.

Alkylation of each present thiol to
form a carbamidomethyl group

Stops alkylation by neutralizing
remaining iodoacetamide

Tryptic digestion of sample

Each digested solution was acidified by the addition of 1 µL formic acid, and extracted with
a modified tip (NuTip®, C18, 10 µL) according to the protocol96 described in Table 3.3.
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Table 3.3: Employed NuTip (NT1C18, 10 µL) protocol to desalt and concentrate tryptic digests
of collected fractions

10 µL acetonitrile
10 µL 0.1% formic acid
Sample solution

Up&Down pipetting
(number of repetitions)
3
3
10

10 µL 0.1% formic acid

6

4 µL 0.1% formic acid
in 60% acetonitrile

10

Solvent/solution

Purpose
Pre-conditioning of NuTip®
Solvent discarded after each repetition
Loading of ZipTip
Washing step;
Solvent discarded after each repetition
Elution/concentration of retained
sample

The concentrated and purified samples were spotted with CHCA in dried droplet (Table 2.2),
and analyzed with the Ultraflex III ToF/ToF instrument. The system was used in the reflectron
mode to obtain overview spectra of the tryptic digest fragments, and, additionally, molecules of
abundant ion signals were fragmented in the LIFT mode to elucidate ion composition.58

3.1.8. Identification of putative biomarker through peptide sequence database search
As discussed in the introduction, a common approach to identify proteins is based on the
analysis of peptide fragments of the target molecule(s) which are in a m/z range (<20 kDa)
amenable to routine mass spectrometric analysis. The peptide fragments for this so-called
“bottom-up” approach are obtained through proteolytic digestion of the sample.36 The enzyme
trypsin is widely employed for its stability under a wide range of conditions, and its high
selectivity to cleave polypeptide chains at the C-terminal side of the amino acids arginine (R)
and lysine (K).97 This specificity of cleavage sites allows the prediction of fragments from
protein sequences, so that matching the experimentally observed mass of the intact and the
tryptic fragments can lead to the identification of the polypeptide. For this, however, the mass
spectral data has to be searched against a peptide sequence data base that already contains
protein sequence information of the investigated organism.37 In this work, the search engine
MASCOT98 was used to match the mass spectral data against protein sequences from the UniProt
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database.99 To gain additional information on the analyte, and hence increase the confidence in
the assignment, the PSD fragments of the tryptic peptides were investigated with the Ultraflex
ToF/ToF in the LIFT mode, and this combined information was used in the data base search. The
search criteria were set to “taxonomy: Rattus”, “enzyme: Trypsin”, “global modification:
carbamidomethyl (C)” (fixed modification introduced in the digestion protocol), “variable
modification: oxidation (M)”, “Mass tol. MS: 0.5 Da”, “Charge state: +1”, “monoisotopic”, and
as instrument: “MALDI-TOF-TOF”.

3.1.9. Interpretation of PSD spectra – nomenclature and systematic
In the PSD of peptides, the majority of the formed fragment ions are the result of cleavage
along the peptide’s backbone.100 The mass spectral data on these can be used to elucidate
information on the sequence of the intact parent peptide, as well as on potential modifications of
the constituting amino acids.37 Figure 3.2 uses Biemann’s modified version101 of the Roepstorff
nomenclature,102 displaying the generic polypeptide sequence of Alanine(A)-Glutamic acid(E)Leucine(L)-Serine(S) to illustrate C- and N-terminal fragments produced by cleavage along the
peptide bond. If the proton remains on the N-terminal fragment, b-type ions are produced, while
remaining on the C-terminal fragment, y-type ions are observed. The index on each series further
indicates how many amino acids the respective ion contains. Additional to this nomenclature,
Figure 3.2 also indicates the molecular composition of E and L along with the monoisotopic
mass. It should be noted that, as opposed to the mass of individual amino acids, these masses are
reduced by the mass of H2O. This so-called residual mass is due to formation of the peptide
bonds within the polypeptide chain, and the concomitant elimination of one H-group at the Nterminus, and the OH-group at the C-terminus of the amino acids within the chain.
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Consequently, the mass of an intact, protonated peptide is the sum of all the residual amino
acid masses plus the mass of H2O (from both termini) and of one proton, [MH + H2O]+ (M
represents the sum of amino acid residues). Further, this explains that protonated ion fragments
from the y-series would comprise [MH + OH]+, while b-ions would be composed of [MH + H]+,
each representing the contribution of the related terminal group. The underlying polypeptide
sequence can, ideally, be deduced by considering the mass difference of two ion fragments
produced from cleavage of adjacent peptide bonds. So, in the depicted example, the mass
difference of y3 and y2 fragment ions is the residual mass of E (129.04 Da), which is exactly
what the comparison of b1 and b2 fragment ions would reveal. Thus, the sequence can be “read”
from the mass spectrum through either fragment ion series, provided individual ion fragment
intensity permits the assignment. Important here is that, in the interpretation, the difference is
denoted as [M], [M + OH], or [M + H], without the proton and its charge.37

Figure 3.2: Polypetide sequence of Alanine(A)-Glutamic acid(E)-Leucine(L)-Serine(S),
illustrating b- and y-type ions produced by cleavage of peptide bonds. Brackets are used for E
and L to indicate the composition comprising the residual mass of each amino acid along with
the respective monoisotopic masses.
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According to these rules, the PSD spectra produced from the LIFT mode were analyzed for
y- and b-type ion series to confirm tryptic peptide fragment sequences obtained in the database
search. Mass differences were annotated when observed difference where within +/- 0.05 Da of
the respective residual mass, and for ambiguous identifications, both residues were presented.
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3.2. Results and discussion
Figure 3.3 depicts an overview of base peak chromatograms (BPC) in the range of 0 to 25
minutes of lysates from quiescent (top), LPS activated (middle), and IL-4 activated (bottom)
macrophages. Lysates were prepared as described above under 3.1.2. and separation was
according to elution conditions in Table 3.1. As described above in 3.1.6. , the mass spectra
constituting each chromatogram were individually investigated for the presence of reproducible
ion signals (S/N < 5, and a minimum of 3 charge states per molecule).
In general, it should also be noted that the employed workflow is targeting hydrophilic
molecules, which could be extracted from the sample with distilled water.

3.2.1. Reproducibility of LC-MS signal intensity
Table 3.4 summarizes the results of testing the LC-MS system for the reproducibility of ion
signal intensity. For each eluting molecule, the average peak area of the respective EIC was
calculated, and the corresponding relative standard deviation (RSD) is given. The tendency of
increased RSD with lower relative peak area can be observed, indicating that more intense
signals would serve as more robust indicator for the purpose of distinguishing activation states
based on molecular fingerprints. The weighted RSD of 6.0% was calculated according to
Equation 3.1, and illustrates the reproducibility of the employed LC-MS system with respect to
ion signal intensity.

Equation 3.1: Formula used to calculate the weighted RSD of n integrated peak areas
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Figure 3.3: Representative base peak chromatograms (BPC) in the range of 0 to 25 minutes of lysates from quiescent (top), LPS
activated (middle), and IL-4 activated (bottom) cells. Lysates were prepared according to 3.1.2. and separation was according to
elution conditions in Table 3.1.

Table 3.4: Resulting relative standard deviations of ion signal obtained in LC-MS experiments on 30 µL aliquots (three) of quiescent
macrophage lysate.
Average retention time
[min]
8.6
10.0
11.3
13.1
13.7
14.9
16.6
18.8
20.4
21.3
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Average area
Relative peak
Relative standard
[a.u.]
area
deviation
7.50E+05 8.23E+05 8.29E+05
8.00E+05
0.48%
5.5%
8.26E+07 8.49E+07 8.86E+07
8.54E+07
50.79%
3.6%
1.16E+06 1.31E+06 1.75E+06
1.40E+06
0.83%
21.9%
7.55E+05 4.27E+05 6.47E+05
6.10E+05
0.36%
27.4%
2.64E+06 2.90E+06 2.91E+06
2.82E+06
1.68%
5.4%
1.98E+06 2.92E+06 3.12E+06
2.67E+06
1.59%
22.8%
6.45E+06 6.42E+06 5.58E+06
6.15E+06
3.66%
8.0%
2.91E+07 2.87E+07 3.16E+07
2.98E+07
17.73%
5.2%
2.50E+07 2.93E+07 2.63E+07
2.69E+07
15.99%
8.3%
1.06E+07 1.32E+07 1.10E+07
1.16E+07
6.90%
12.1%
weighted relative standard deviation:
6.0%
For each of the 10 eluting peaks, the EIC of all related charge states (ion signal in mass spectra S/N > 5, minimum of 3 charge
states) in each technical replicate was integrated, and the relative standard deviation (RSD) of the average area was calculated. The
relative peak area was calculated (average area of peak divided by sum of all average areas) and used to obtain the weighted RSD
(sum of RSDs multiplied by relative peak areas) to account for the tendency of less intense signal to have a higher RSD. The
weighted RSD illustrates the reproducibility of the ion signal intensities of the employed LC-MS system
Area [a.u.]

3.2.2. Analysis of ion signals present under quiescent, IL-4 and LPS-induced condition
A statistical treatment of the data on IL-4 was not feasible, since only 4 biological replicates
of this condition were analyzed, of which only two would have had a strong enough signal of the
observed, eluting molecules, so only the quiescent and the LPS-induced condition were
compared. Table 3.5 gives an overview of all 9 common molecules detected by LC-MS of lysate
from quiescent (white background) and LPS-induced (grey background) macrophages. The
average relative areas and the related standard deviation for of each ion signal pair (quiescent
and LPS-induced) were evaluated using t-tests (unpaired, two-tailed, equal variance or unequal
variance (based on individual F-test). In each case, the difference was significant at the threshold
level of p=0.01, suggesting that the obtained molecular fingerprint can be used to differentiate
between lysates from quiescent and LPS-induced cell cultures.

3.2.3. Molecule eluting at minute 21.5 as strong indicator for LPS-induction of macrophages
Visually comparing the LC-MS chromatogram of quiescent and LPS-induced macrophages
revealed one ion signal (eluting after ≈21.5min) that was only present (at the threshold of S/N >
5) in lysate from quiescent macrophages, but not from lysate obtained from LPS-induced ones.
Figure 3.4 displays a representative mass spectrum of this molecule, along with the mass spectra
representing the other two prominent peaks (see Figure 3.3.) at minute 18.5 (top) and 20.0
(middle). The ion signals could be deconvoluted to obtain the ion masses of 8451.8 Da (top),
10815.9 Da (middle), and 3990.5 Da (bottom), which could be also confirmed through the
fraction collection experiment, and the following MALDI experiment on the dried fractions
(Figure 3.6, corresponding ions marked with a star).
Using the m/z of each charge state of each molecule highlighted in Figure 3.4, an extracted
ion chromatogram (EIC) was generated for each LC-MS experiment on lysate from quiescent
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and LPS-induced macrophages. Figure 3.5 displays an overlay of EIC constructed this way of
each 5 biological replicates lysate from quiescent (top) and LPS-induced macrophages (bottom),
demonstrating the absence of the molecule eluting at minute 21.5 after activation with LPS.
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Table 3.5: Summary of the relative peak areas of all 9 common molecules detected by LC-MS of lysate from quiescent (white
background) and LPS-induced (grey background) macrophages.
Average, relative peak areas of signals found in lysate
Standard
from quiescent (white background) and LPS-induced
F-test
t-test
deviation
(grey background) macrophages [n = 10] [%]
7.5
1.80
0.51
2664.7
8.75 x 10-5 9.80 x 10-6 *
7.5
0.44
0.11
9.9
46.94
6.76
4964.0
8.65 x 10-3 4.73 x 10-4 *
9.9
35.94
2.59
11.2
1.06
0.20
3790.9
4.55 x 10-2 8.53 x 10-10
11.2
0.26
0.10
13.1
0.50
0.16
4356.9
2.11 x 10-3 2.82 x 10-4 *
13.1
0.22
0.05
13.7
2.20
0.44
4971.0
7.83 x 10-2 1.08 x 10-7
13.7
0.87
0.23
14.9
2.24
0.57
5199.4
1.08 x 10-3 1.71 x 10-6 *
14.9
0.47
0.16
16.6
2.20
0.55
7886.7
7.88 x 10-1 1.51 x 10-3
16.6
3.17
0.61
18.7
25.91
5.04
8453.3
9.85 x 10-1 2.07 x 10-3
18.7
34.04
5.07
20.4
17.15
1.88
10816.9
1.25 x 10-3 4.85 x 10-3 *
20.4
24.59
6.36
Experiments performed on 10 biological replicates each. The variance of each average relative peak area was compared (quiescent
vs LPS-induced) with the F-test, and the means were accordingly evaluated using t-tests (unpaired, two-tailed, equal or unequal
variance (based on the corresponding F-test, * denotes unequal variance at p = 0.01)). For each molecule, the difference was
significant at the threshold level of p=0.01.
m/z
[Da]

Average RT
[min]
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Figure 3.4: Representative mass spectra from a LC-MS experiment on quiescent macrophage
lysate. The spectra are of the three prominent peaks (see Figure 3.3.) at minute 18.5 min (top),
20.0 min( middle), and 21.5 min (bottom). The ion peaks are additionally labeled with the
calculated charge states, and the deconvoluted masses are given as 8451.8 Da (top), 10815.9 Da
(middle), and 3990.5 Da (bottom).
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Figure 3.5: Overlay of extracted ion chromatograms (EIC) obtained from lysate of quiescent (top) and LPS-activated
macrophages (5 biological replicates each), demonstrating the absence of the molecule eluting at minute ≈21.5. The lysates were
separated according to Table 3.1, and the EIC were constructed by integrating all displayed m/z (+/- 0.5 Da) in Figure 3.4.
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Figure 3.6:MALDI mass spectra of macrophage lysate fractions collected at minute 18-19 (top), minute 20-21 (middle), and
minute 21-22 (bottom). Ion signals corresponding to the dominant ESI-MS signal (Figure 3.4) are highlighted with a star in
the respective spectrum. Lysate fraction were prepared in SA, as described above (3.1.5. )

3.2.4. Identification of putative biomarker for LPS-activation as macrophage-capping protein
Figure 3.7 gives an overview of the information obtained on the intact molecule eluting at
minute ≈21.5. Since the absence of this molecule indicates LPS-activation, the presented data is
on lysate from quiescent macrophages where the molecule is detectable. The bottom right
displays an ESI mass spectrum, while the bottom left depicts the MALDI mass spectrum of the
corresponding dried fraction. The ESI signal deconvolutes to the average molecule mass of
3990.5 Da, while the MALDI data shows the monoisotopic mass of 3988.4 Da. This slight
difference in mass is based on the mathematical nature of averaging the m/z signal in the case of
the ESI signal (i.e. unresolved isotopic pattern) vs the isotopically resolved MALDI spectrum
(ToF instrument was used in reflectron mode). Further, the MALDI spectrum exhibits another
peak lower in mass with the difference in mass matching the atomic mass of one oxygen atom
(=16.0 Da), suggesting that the base peak contains one oxidized group.
Figure 3.8 depicts the mass spectrum obtained on the tryptic digest of the biomarker
containing fraction. The inset further presents the sequence of the protein fragment (amino acid
position 305-339, which represents 7% of the entire protein sequence) of the protein
“macrophage-capping protein”, which was the only significant (p < 0.05) result of the data base
search. The theoretical, protonated, and oxidized mass of this sequence, 3988.1 Da, is in very
good agreement with the experimentally observed mass of 3988.4 Da (Figure 3.7). The two
predicted tryptic fragments of 1375.7 Da and 1601.8 Da, which cover 77% of the depicted
sequence, are both present in the spectrum (1375.7 Da and 1601.7 Da, respectively). To confirm
this assignment, the PSD spectra of both tryptic fragments were analyzed based on the suggested
sequence.
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Figure 3.9 depicts the PSD spectrum of the ion isolated at 1375.7 Da (isolation window +/3%). The sequence elucidated from the annotated b-ion series supports the assignment, and is
further backed by the prominent peak at 579.1 Da representing the y5 fragment ion. Additionally,
the theoretical ion mass differences are in excellent agreement (within 0.2 Da error) of the
observed mass differences. It has to be noted that the amino acids lysine (K) and glutamine (Q),
with a residual mass difference of 0.03 Da, cannot be unambiguously assigned, nor the stereo
isomers leucine (L) and isoleucine (I).
Figure 3.8 depicts the PSD spectrum of the ion isolated at 1601.7 Da (+/- 3%). The sequence
elucidated from the annotated y-ion series supports the suggested sequence, and the theoretical
ion mass differences compare very well (within 0.7 Da error) with experimentally observed
differences.
In conclusion, the identification of the putative biomarker as part of the macrophage-capping
protein can be supported on multiple levels. Through the excellent agreement of the theoretical
and observed intact and tryptic fragments masses. Further, through the presence of these tryptic
fragments with specificity of each fragment as being the product of the cleavage of each Cterminal arginine (R), and the total sequence coverage of 77% through both tryptic fragments.
The postulated sequence is further validated through the presence of the annotated sequencespecific fragments in the PSD experiments.
The sequence of the complete protein was originally obtained from a large-scale cDNA
project,103 and the human ortholog was described by Dabiri et al. to be abundantly expressed
only by macrophages.104 Further, the observed behavior of this molecule being absent within the
macrophages upon activation with LPS is demonstrated through complimentary results from
Eichelbaum et al.31 In their study targeting the protein synthesis and secretion during
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macrophage activation of RAW 264.7 (mouse macrophage), they could show that the mouse
ortholog of the macrophage capping protein was not newly synthesized upon stimulation with
LPS (within 8 h after stimulation), but that it was released from the macrophages into the culture
medium (8 h after stimulation, LPS stimulated media contained approximately 5.5 times more of
the compound identified as macrophage capping protein than the quiescent control
macrophages).31 If similar behavior of the investigated rat macrophages can be assumed, this
confirms the observation of this study that upon LPS stimulation, the peptide related to the
macrophage capping protein is not found (below level of detection) within the macrophage
lysate.
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Figure 3.7: Overview of representative mass spectra collected on the putative biomarker. The top displays an EIC of lysate
from quiescent macrophages with the signal corresponding to the molecule eluting at minute ≈21.5 highlighted. The bottom
right displays the ESI mass spectrum with the deconvoluted m/z of 3990.5 Da, while the bottom left depicts an isotopically
resolved (ToF in reflectron mode) MALDI mass spectrum of the corresponding dried fraction spotted in SA. The inset of the
MALDI spectrum shows the enlarged range from 3974-3996 m/z, exhibiting the monoisotopic peak (3988.4 Da) of the base
peak, and an adjacent peak at 3972.39 Da. The difference of 16.0 Da suggests the presence of an additional oxygen atom
(=16.0 Da). Note: the mass spectra are of lysate from quiescent macrophages, but the absence of this signal serves as
indication for LPS-activation.
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Figure 3.8: Mass spectrum of tryptic fragments from the digestion experiment on the fraction containing the putative biomarker.
The inset contains the sequence fragment (amino acid position 305-339) returned in the MASCOT database search of the depicted
spectrum. The theoretical masses of the entire sequence, as well as of both tryptic fragments are indicated.
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Figure 3.9: LIFT spectrum of ion 1375.7 Da (isolation window of +/- 3%) exhibiting mainly b-ion series fragments. The spectrum
is annotated with amino acids corresponding to observed mass differences along with the theoretical values of the respective
sequences in the inset. Additionally, the dominant peak at 579.1 Da is labeled as the y5 ion. Ambiguity in assignment is indicated
by providing both potential amino acids. The obtained sequence information supports the proposed sequence for this tryptic
fragment.
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Figure 3.10: LIFT spectrum of ion 1601.7 Da (isolation window of +/- 3%) exhibiting y-ion series fragments. The spectrum is
annotated with amino acids corresponding to observed mass differences along with the theoretical values of the respective
sequences in the inset. The obtained sequence information supports the proposed sequence for this tryptic fragment.

Chapter 4: Summary and future direction
Macrophages are versatile and highly adaptive cells that are involved in a wide range of
physiological processes ranging from host defense, over homeostasis or regeneration, to
pathogenesis.3-5,12,31,32,44,45,47 They react to their microenvironment, assuming various roles based
on chemical and/or physical cues.1,3,6,7,16 It has been proposed that macrophages exist along a
continuous spectrum in between these so-called activation states,13 and it was shown that
macrophages can be reversibly shifted between activation states.15-17,19 Since the
microenvironment is significant to macrophage activation, it is desirable to obtain information on
spatial distribution along with the activation state of macrophages on tissue sections. This
information is currently predominantly obtained through an immunohistochemistry approach.50
The aim of this work was to explore the application of mass spectrometry to the task of
distinguishing macrophage activation states. The assumption that significant differences in
molecular composition correlates with observed activation states is based on high-throughput
proteomics experiments, revealing distinct protein levels attributed to activation with LPS.30,31
The intention was to investigate whether MALDI MS conditions could be found that permit
identification of macrophage activation states within tissue sections.
In Chapter 2, the sample preparation technique of matrix-assisted laser desorption/ionization
(MALDI) was explored to evaluate its use for MALDI imaging mass spectrometry (IMS)
experiments, which could reveal activation state, spatial distribution, and concentration of
macrophages within tissue sections. As model, the immortalized macrophage cell line NR8383
(rat, alveolar) was cultured and in vitro activated with either the cytokine IL-4, or the endotoxin
LPS. Despite varying core parameters like the employed matrices, sample preparation
techniques, and employed solvents for sample extraction, no reproducible mass spectral
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fingerprint of macrophage was observed that could indicate a difference in the induced activation
state. It could be observed that the mass spectral fingerprint, especially in the range of 4000 –
6500 m/z (compare inset Figure 2.3), appeared to be well conserved across differing activation
states (Figure 2.9), differing extraction solvents (Figure 2.6), and, to a certain degree, across
different employed matrices (Figure 2.1). It was concluded that, despite the reported differences
in molecular composition correlating LPS activation, the signals from these biomarkers were
suppressed by the relative strong ionizability of the molecules constituting this conserved mass
spectral fingerprint.
Chapter 3 describes the introduction of high-performance liquid chromatography (HPLC) as
a mean to reduce the molecular sample complexity, as well as electrospray ionization (ESI) as an
alternative to MALDI as the mass spectrometry source. Comparison of normalized signal
intensities obtained on macrophage lysate from quiescent and LPS-induced in the LC-ESI-MS
experiments revealed reproducible differences in the relative intensities of the eluting
compounds. Within 10 biological replicates of the LPS-activated vs the quiescent state separated
under identical elution conditions, the relative ion intensities of 9 common ions were compared.
A significant (p < 0.01) difference was observed for each common ion, suggesting that the 30
min separation protocol would allow distinguishing quiescent from LPS-activated macrophages
based on the relative abundance of the investigated signal (Table 3.5). However, a molecule
eluting after 21.5 min could be recognized as strong indicator for LPS activation. In lysate from
quiescent macrophages, the corresponding signal contributed 9 % (+/- 1% standard deviation) of
relative ion signal, while the signal upon LPS activation was absent (Figure 3.5). The average
molecular mass of this putative biomarker was measured by ESI MS to be 3990.5 Da, and
confirmed by the monoisotopic mass of 3988.4 Da measured in a MALDI experiment of the
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corresponding, collected, and dried fraction (Figure 3.7). MALDI experiments on the tryptic
digest containing the putative biomarker supports the identification of it as peptide corresponding
to the amino acid sequence (position 305-339) of the macrophage-capping protein. This finding
is conclusive with the observations made in a proteomics experiment on LPS-induced
macrophages (RAW 264.7, mouse).
Based on the identification of this peptide, further work could include its use as an alternative
indicator for LPS-activation of macrophages. For this, the presence of this marker in
macrophages harvested from various tissues and organisms would have to be established, as well
as its absence under LPS-activation. Based on the observation that the peptide is soluble in water
(as used for the extraction), but will adhere to the column material (ø 5 µm particles, modified
with C18, and containing 300 Å micro pores), and will only elute after reaching approximately
36% acetonitrile content, could be used to concentrate and detect it from media with the help of
accordingly modified pipette tips.105
Further, based on the high specificity of this biomarker for macrophages,104 it could be used
for mapping of the spatial distribution of quiescent macrophages on tissue sections. For this,
liquid extraction based mass spectrometry methods have been proposed as alternative for the
analysis of tissue sections,85-87 as well as automated, semi-continuous techniques compatible
with HPLC88-90 could be used.
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